2018
DOI: 10.1074/jbc.ra118.003285
|View full text |Cite
|
Sign up to set email alerts
|

Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer

Abstract: The functionality of the tumor suppressor p53 is altered in more than 50% of human cancers, and many individuals with cancer exhibit amyloid-like buildups of aggregated p53. An understanding of what triggers the pathogenic amyloid conversion of p53 is required for the further development of cancer therapies. Here, perturbation of the p53 core domain (p53C) with subdenaturing concentrations of guanidine hydrochloride and high hydrostatic pressure revealed native-like molten globule (MG) states, a subset of whic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
39
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(41 citation statements)
references
References 53 publications
2
39
0
Order By: Relevance
“…The numerous studies on p53 DBD aggregation suggest that it follows the general model of amyloid formation: monomer → misfolded monomer → dimer → oligomer → protofibril → mature fibril (Figure 4). Under sub-denaturing concentrations of guanidine hydrochloride, the structural ensemble of the p53 DBD can be shifted to populate swollen molten globule states with native like secondary and tertiary structure, and accelerated aggregation kinetics [78]. An open question is to define the oligomeric/multimeric species of mutant p53 or altered p53 that exert GoF activity resulting in higher malignancy.…”
Section: P53 Aggregation Mechanism and Treatment Optionsmentioning
confidence: 99%
See 1 more Smart Citation
“…The numerous studies on p53 DBD aggregation suggest that it follows the general model of amyloid formation: monomer → misfolded monomer → dimer → oligomer → protofibril → mature fibril (Figure 4). Under sub-denaturing concentrations of guanidine hydrochloride, the structural ensemble of the p53 DBD can be shifted to populate swollen molten globule states with native like secondary and tertiary structure, and accelerated aggregation kinetics [78]. An open question is to define the oligomeric/multimeric species of mutant p53 or altered p53 that exert GoF activity resulting in higher malignancy.…”
Section: P53 Aggregation Mechanism and Treatment Optionsmentioning
confidence: 99%
“…Structurally destabilizing p53 DBD mutations can result in a similar outcome [43]. As such, native-state stabilization is a primary avenue being explored to impede p53 DBD aggregation [23,78]. Most approaches to date endeavor to use small molecules to stabilize particular mutants, with the majority of efforts focusing on the cavity induced by the Y220C hotspot mutation [79].…”
Section: P53 Aggregation Mechanism and Treatment Optionsmentioning
confidence: 99%
“…This suggests the low‐salt conformation may resemble an intermediate in the folding process. Interestingly, p53 MG conformers are highly prone to aggregation and amyloid‐like oligomers . The same could occur with cl‐Par‐4 MG conformers.…”
Section: Discussionmentioning
confidence: 88%
“…For example, prion-forming sequences, which are especially enriched in asparagine, have been shown to promote molten globule-like structures, in which amyloid-nucleating contacts can be made [55,56]. Mutant forms of the tumor suppressor protein, p53, have recently been shown to behave as molten globules while exhibiting prion-like properties and, although its standard functions are strongly connected to tumor suppression, p53 mutants and aggregates are involved in cancer progression [57,58].…”
Section: Resultsmentioning
confidence: 99%